Active 0 6 0 6 B-chronic_disease
life 7 11 7 11 I-chronic_disease
- 11 12 11 12 I-chronic_disease
threatening 12 23 12 23 I-chronic_disease
infection 24 33 24 33 I-chronic_disease

BM 0 2 34 36 B-cancer
metastases 3 13 37 47 I-cancer
or 14 16 48 50 O
MIBG 17 21 51 55 B-cancer
- 21 22 55 56 I-cancer
avid 22 26 56 60 I-cancer
lesion(s 27 35 61 69 I-cancer
) 35 36 69 70 I-cancer
plus 37 41 71 75 O
high 42 46 76 80 O
urine 47 52 81 86 O
catecholamine 53 66 87 100 O
levels 67 73 101 107 O

Human 0 5 108 113 B-clinical_variable
anti 6 10 114 118 I-clinical_variable
- 10 11 118 119 I-clinical_variable
hu3F8 11 16 119 124 I-clinical_variable
antibody 17 25 125 133 I-clinical_variable
( 26 27 134 135 I-clinical_variable
HAHA 27 31 135 139 I-clinical_variable
) 31 32 139 140 I-clinical_variable
titer 33 38 141 146 I-clinical_variable
> 39 40 147 148 O
1300 40 44 148 152 B-lower_bound
Elisa 45 50 153 158 I-lower_bound
unites 51 57 159 165 I-lower_bound
/ 57 58 165 166 I-lower_bound
ml 58 60 166 168 I-lower_bound

Patients 0 8 169 177 O
must 9 13 178 182 O
have 14 18 183 187 O
high 19 23 188 192 O
- 23 24 192 193 O
risk 24 28 193 197 O
NB 29 31 198 200 O
( 32 33 201 202 O
MYCN 33 37 202 206 B-clinical_variable
- 37 38 206 207 I-clinical_variable
amplified 38 47 207 216 I-clinical_variable
stage 48 53 217 222 I-clinical_variable
2/3/4/4S 54 62 223 231 B-lower_bound
of 63 65 232 234 O
any 66 69 235 238 O
age 70 73 239 242 O
and 74 77 243 246 O
MYCN 78 82 247 251 O
- 82 83 251 252 O
nonamplified 83 95 252 264 O
stage 96 101 265 270 O
4 102 103 271 272 O
in 104 106 273 275 O
patients 107 115 276 284 O
greater 116 123 285 292 O
than 124 128 293 297 O
18 129 131 298 300 B-lower_bound
months 132 138 301 307 I-lower_bound
of 139 141 308 310 O
age 142 145 311 314 O

